Microemulsion Technology provides Podiatrists with better penetration and better results. With small particle size Formula 7®’s antibacterial and antifungal properties deliver the benefit of multiple products in a single tube or jar. The leader in Tolfnaftate Technology since 1986! Formula 7®is the first tolnaftate microemulsion utilizing soluble tolnaftate, the technology developed by the Tetra Corporation.
The increase in the use of telehealth services during the pandemic coincided with a decrease in opioid overdoses among Medicaid beneficiaries, according to a new study.
New messaging from the Biden administration suggests that vaccination against COVID-19 will soon follow a similar pattern to that of influenza vaccination.
Editor's note: APMA, the CDC, and CMS provide information, recommendations, and guidance regarding the COVID-19 vaccination.
Power Diary now includes a complete Practice Operations Manual providing a set of policies and procedures that practices can configure to meet their businesses' needs, set standards for the workplace, and maintain professional operations. Developed by a team with over 50 years of industry experience, this game-changing feature is available exclusively to all Power Diary customers!
